John Azietaku

John Azietaku is a Research Fellow at Monash University's Department of Drug Discovery Biology, specializing in analytical methods for drug metabolism, traditional Chinese medicine (TCM) research, and pharmacokinetics. His work focuses on developing advanced LC-MS/MS and HPLC techniques for quantifying bioactive compounds in biological matrices, particularly in herbal extracts and pharmaceutical formulations.

Key research interests include chemometric methods for herbal standardization, tissue distribution studies of natural products, and investigating enzyme inhibition (e.g., CYP450) effects of TCM preparations. He has conducted extensive pharmacokinetic analyses of compounds like bergapten, periplocin, and Columbianadin in rat models, emphasizing metabolite identification and bioavailability.

His publications highlight methodological innovations in simultaneous quantification of multi-components and application of bioactivity-guided approaches for drug discovery. While no awards are explicitly mentioned, his contributions to analytical methodologies in TCM research are notable. He has no listed advisees or grants in the provided data. His research is closely tied to the Drug Discovery Biology team at Monash, focusing on translational applications of analytical chemistry in pharmaceutical development.